通过将过继性T细胞疗法与鼠伤寒沙门氏菌联合使用来预防肿瘤复发。
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.
作者信息
Binder David C, Arina Ainhoa, Wen Frank, Tu Tony, Zhao Ming, Hoffman Robert M, Wainwright Derek A, Schreiber Hans
机构信息
Committee on Cancer Biology, University of Chicago, Chicago, IL, USA; Department of Pathology, University of Chicago, Chicago, IL, USA.
Department of Pathology, University of Chicago, Chicago, IL, USA; Committee on Immunology, The University of Chicago, Chicago, IL, USA.
出版信息
Oncoimmunology. 2016 Feb 18;5(6):e1130207. doi: 10.1080/2162402X.2015.1130207. eCollection 2016 Jun.
Abstract
We recently reported that therapeutic vaccination with live tumor antigen-producing Salmonella typhimurium rescues dysfunctional endogenous T cell responses and eradicates long-established tumors refractory to αCTLA-4 and αPD-L1 checkpoint inhibitor blockade. Here, we show that live intravenously injected or heat-killed (HK) intratumorally injected Salmonella typhimurium, even when not producing tumor antigen, synergize with adoptive T cell therapy to eradicate tumors. These data demonstrate that the combination of adoptive T cell transfer with the injection of live or dead Salmonella typhimurium is a promising approach for cancer treatment.
摘要
我们最近报道，用产生活肿瘤抗原的鼠伤寒沙门氏菌进行治疗性疫苗接种可挽救功能失调的内源性T细胞反应，并根除对αCTLA-4和αPD-L1检查点抑制剂阻断有抗性的长期存在的肿瘤。在此，我们表明，静脉内注射活的或瘤内注射热灭活（HK）的鼠伤寒沙门氏菌，即使不产生活肿瘤抗原，也能与过继性T细胞疗法协同作用以根除肿瘤。这些数据表明，过继性T细胞转移与注射活的或死的鼠伤寒沙门氏菌相结合是一种很有前景的癌症治疗方法。
相似文献
1
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.
Oncoimmunology. 2016 Feb 18;5(6):e1130207. doi: 10.1080/2162402X.2015.1130207. eCollection 2016 Jun.
2
Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.
Cancer Immunol Res. 2013 Aug;1(2):123-33. doi: 10.1158/2326-6066.CIR-13-0058.
3
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 T cell immunity to reject 'cold' tumors.
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003488.
4
Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines.
Infect Immun. 1983 Aug;41(2):751-7. doi: 10.1128/iai.41.2.751-757.1983.
5
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Clin Cancer Res. 2019 Mar 1;25(5):1612-1623. doi: 10.1158/1078-0432.CCR-18-1932. Epub 2018 Dec 11.
6
Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors.
PLoS One. 2012;7(7):e41240. doi: 10.1371/journal.pone.0041240. Epub 2012 Jul 20.
7
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
J Crohns Colitis. 2017 Oct 1;11(10):1238-1246. doi: 10.1093/ecco-jcc/jjx081.
8
Role of IL-12-independent and IL-12-dependent pathways in regulating generation of the IFN-gamma component of T cell responses to Salmonella typhimurium.
J Immunol. 2002 Sep 1;169(5):2545-52. doi: 10.4049/jimmunol.169.5.2545.
9
Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.
Oncoimmunology. 2021 Jun 27;10(1):1940676. doi: 10.1080/2162402X.2021.1940676. eCollection 2021.
10
Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors.
Front Immunol. 2018 Jan 16;8:1993. doi: 10.3389/fimmu.2017.01993. eCollection 2017.
引用本文的文献
1
Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.
Adv Sci (Weinh). 2023 Apr;10(12):e2205641. doi: 10.1002/advs.202205641. Epub 2023 Mar 12.
2
Recombinant Attenuated as a Delivery System of Heterologous Molecules in Cancer Therapy.
Cancers (Basel). 2022 Aug 30;14(17):4224. doi: 10.3390/cancers14174224.
3
Highlights of Immunomodulation in -Based Cancer Therapy.
Biomedicines. 2021 Oct 29;9(11):1566. doi: 10.3390/biomedicines9111566.
4
flagella confer anti-tumor immunological effect activating Flagellin/TLR5 signalling within tumor microenvironment.
Acta Pharm Sin B. 2021 Oct;11(10):3165-3177. doi: 10.1016/j.apsb.2021.04.019. Epub 2021 May 7.
5
Integration of into Combination Cancer Therapy.
Cancers (Basel). 2021 Jun 28;13(13):3228. doi: 10.3390/cancers13133228.
6
Perspectives on Oncolytic in Cancer Immunotherapy-A Promising Strategy.
Front Immunol. 2021 Feb 25;12:615930. doi: 10.3389/fimmu.2021.615930. eCollection 2021.
7
-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy.
Biomedicines. 2019 May 2;7(2):36. doi: 10.3390/biomedicines7020036.
8
Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.
Microb Biotechnol. 2017 Sep;10(5):1074-1078. doi: 10.1111/1751-7915.12787. Epub 2017 Aug 3.
9
Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.
Oncotarget. 2017 Jul 25;8(30):49988-50001. doi: 10.18632/oncotarget.18392.
10
The Boosting Potential of Bacteria in Cancer Immunotherapy.
Trends Mol Med. 2017 Jul;23(7):580-582. doi: 10.1016/j.molmed.2017.05.008. Epub 2017 Jun 2.
本文引用的文献
1
Image-guided drug delivery: preclinical applications and clinical translation.
Expert Opin Drug Deliv. 2015 Aug;12(8):1203-7. doi: 10.1517/17425247.2015.1059420. Epub 2015 Jun 17.
2
Adoptive cell transfer as personalized immunotherapy for human cancer.
Science. 2015 Apr 3;348(6230):62-8. doi: 10.1126/science.aaa4967.
3
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.
4
Chimeric antigen receptor T cells for sustained remissions in leukemia.
N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa1407222.
5
Current concepts in the diagnosis and management of cytokine release syndrome.
Blood. 2014 Jul 10;124(2):188-95. doi: 10.1182/blood-2014-05-552729. Epub 2014 May 29.
6
The mechanism of action of BCG therapy for bladder cancer--a current perspective.
Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4.
7
Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.
Cancer Immunol Res. 2013 Aug;1(2):123-33. doi: 10.1158/2326-6066.CIR-13-0058.
8
Tumour heterogeneity and cancer cell plasticity.
Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624.
9
Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma.
J Clin Oncol. 2013 Nov 10;31(32):e439-42. doi: 10.1200/JCO.2012.47.7521. Epub 2013 Sep 16.
10
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.
Nat Med. 2013 Jun;19(6):747-52. doi: 10.1038/nm.3161. Epub 2013 May 5.
Zotero 插件